Trial intelligence / Profile preview

Phase IIa randomized double-blind PK trial of BioChaperone rhInsulin vs insulin aspart

2011-001291-19Phase 2Completed

Sponsor
Adocia
Start
Mar 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Adocia. Primary endpoint: Time to reach maximal insulin concentration (TINSmax). Started Mar 2011; status: completed.

02

Drugs

human insulin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2011-001291-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001291-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call